Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Protease inhibitors in development at SmithKline Beecham

April 30, 1999

Amylin's pramlintide given trademark

April 30, 1999

Purified flaxseed lignan has significant beneficial effects in hypercholesterolemic atherosclerosis

April 29, 1999

New cyclic compounds designed at JT reduce only elevated blood glucose levels

April 27, 1999

New phenylpropionic acid derivatives with excellent antidiabetic effects

April 27, 1999

FDA approves Roche's lipase inhibitor for marketing

April 27, 1999

SmithKline Beecham enters copromotion agreement with Bristol-Myers Squibb for Avandia

April 26, 1999

HMR seeks approval for long-acting insulin in U.S. and Europe

April 26, 1999

SS Pharm. presents new AGE inhibitors for use in diabetic complications

April 26, 1999

Pharmacokinetics of Prandin shown to be similar in young adults and elderly

April 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...